Story perspectives

Hadassah performs first Alpha DaRT glioblastoma treatment

8/19/2026

Summary

Story summary

Hadassah-University Center in Jerusalem treated a 77-year-old glioblastoma patient with Alpha DaRT technology for the first time.
Professor Yigal Shoshan directed the surgery using the Alpha DaRT system, which injects sources into the tumor and was created with Sharett Institute and ALPHA Tau.
Phase-I testing examines feasibility and safety before efficacy trials, while preclinical studies suggest the approach could trigger an immune response against tumors elsewhere in the brain.

1 of 1

Story summary

Hadassah-University Center in Jerusalem treated a 77-year-old glioblastoma patient with Alpha DaRT technology for the first time.
Professor Yigal Shoshan directed the surgery using the Alpha DaRT system, which injects sources into the tumor and was created with Sharett Institute and ALPHA Tau.
Phase-I testing examines feasibility and safety before efficacy trials, while preclinical studies suggest the approach could trigger an immune response against tumors elsewhere in the brain.